scholarly journals Contact Urticaria with Systemic Symptoms due to Hexylene Glycol in a Topical Corticosteroid: Case Report and Review of Hypersensitivity to Glycols

Dermatology ◽  
2010 ◽  
Vol 220 (3) ◽  
pp. 238-242 ◽  
Author(s):  
D. Spoerl ◽  
K. Scherer ◽  
A.J. Bircher
Keyword(s):  
Case Report ◽  
Topical Corticosteroid ◽  
Contact Urticaria ◽  
Hexylene Glycol ◽  
Systemic Symptoms

Contact urticaria to non‐latex synthetic glove material: A case report

2020 ◽  
Vol 83 (5) ◽  
pp. 417-418
Author(s):  
Sheila M. McSweeney ◽  
Ian R. White ◽  
John P. McFadden ◽  
Christos Tziotzios
Keyword(s):  
Case Report ◽  
Contact Urticaria

scholarly journals Contact urticaria caused by the Apple Watch – A case report

2017 ◽  
Vol 21 (2) ◽  
pp. 84-86 ◽  
Author(s):  
Spencer D. Hawkins ◽  
Steven R. Feldman
Keyword(s):  
Case Report ◽  
Contact Urticaria

scholarly journals Acute Iodine Toxicity from a Suspected Oral Methamphetamine Ingestion

2014 ◽  
Vol 7 ◽  
pp. CCRep.S20086 ◽  
Author(s):  
Marilyn N. Bulloch
Keyword(s):  
Case Report ◽  
Gastrointestinal Symptoms ◽  
Liver Function Tests ◽  
Oral Ingestion ◽  
Methamphetamine Abuse ◽  
Normal Limits ◽  
Naturally Occurring ◽  
History Of ◽  
Systemic Symptoms ◽  
Iodine Toxicity

Background Iodine is a naturally occurring element commercially available alone or in a multitude of products. Iodine crystals and iodine tincture are used in the production of methamphetamine. Although rarely fatal, iodine toxicity from oral ingestion can produce distressing gastrointestinal symptoms and systemic symptoms, such as hypotension and tachycardia, from subsequent hypovolemia. Objective The objective of this case report is to describe a case of iodine toxicity from suspected oral methamphetamine ingestion. Case Report A male in his early 20′s presented with gastrointestinal symptoms, chills, fever, tachycardia, and tachypnea after orally ingesting a substance suspected to be methamphetamine. The patient had elevated levels of serum creatinine, liver function tests, and bands on arrival, which returned to within normal limits by day 4 of admission. Based on the patient's narrow anion gap, halogen levels were ordered on day 3 and indicated iodine toxicity. This is thought to be the first documented case of iodine toxicity secondary to suspected oral methamphetamine abuse. Conclusion Considering that the incidence of methamphetamine abuse is expected to continue to rise, clinicians should be aware of potential iodine toxicity in a patient with a history of methamphetamine abuse.

Rhabdomyolysis in a Female Caucasian Adolescent Distance Runner: A Case Report

2016 ◽  
Vol 21 (6) ◽  
pp. 26-32 ◽  
Author(s):  
R. Mitchell Todd ◽  
Michelle Cleary ◽  
J. Susan Griffith
Keyword(s):  
Case Report ◽  
Laboratory Testing ◽  
Heat Stroke ◽  
Distance Runner ◽  
Heat Illness ◽  
Adolescent Female ◽  
Systemic Symptoms ◽  
Return To Competition

We present the case of an adolescent female collegiate distance runner competing in her first 6K race. She presented with multiple systemic symptoms of dizziness, nausea, confusion, muscle cramping, and syncope. The patient was immediately treated for heat stroke and, on follow-up, reported to the AT with a headache, lack of appetite, muscle aches, and dark-colored urine. Rhabdomyolysis should be considered following a heat illness event with necessary treatments performed immediately. Symptomatic patients must be referred to a physician for evaluation and laboratory testing. We present recommendations for a supervised return-to-participation protocol and acclimatization to safely return to competition readiness.

Probable cutaneous loxoscelism with mild systemic symptoms: A case report from Spain

Toxicon ◽  
2018 ◽  
Vol 156 ◽  
pp. 7-12 ◽  
Author(s):  
Koen Jerusalem ◽  
Miguel Salavert Lletí
Keyword(s):  
Case Report ◽  
Systemic Symptoms

scholarly journals Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report

2018 ◽  
Vol 17 (5) ◽  
pp. 0-10
Author(s):  
Claudio De Vito ◽  
Thomas Papathomas G. ◽  
Federica Pedica ◽  
Pauline Kane ◽  
Ali Amir ◽  
...  
Keyword(s):  
Case Report ◽  
Ct Scan ◽  
Histological Examination ◽  
Plasma Cell ◽  
Hepatocellular Adenoma ◽  
Castleman Disease ◽  
Cell Type ◽  
Aa Amyloidosis ◽  
Plasma Cell Type ◽  
Systemic Symptoms

Systemic symptoms such as fever and fatigue are non-specific manifestations spanning from inflammation to neoplasia. Here we report the case of a 34 year-old man who presented with systemic symptoms for four months. CT-scan and MRI revealed a 3.4 cm arterialized hepatic lesion and a 7 cm paraduodenal mass. Surgical resection of both lesions and histological examination revealed an inflammatory hepatocellular adenoma and a unicentric plasma cell type of Castleman disease. Moreover, a diffuse AA amyloid deposition in the liver was observed. Resection of both lesions was associated with an improvement of the symptoms. To our knowledge, this is the first report of a synchronous presentation of a unicentric plasma cell type of Castleman disease, inflammatory hepatocellular adenoma and AA amyloidosis.

scholarly journals Haemorrhagic suprarenal pseudocysts: a systematic review of a rare condition from family physicians’ perspective during the COVID-19 global pandemic

2021 ◽  
Vol 3 (1) ◽  
pp. 22-25
Author(s):  
Adekunle Olowu ◽  
Adel Abbas Alzehairy
Keyword(s):  
Case Report ◽  
Primary Care Physicians ◽  
Rare Condition ◽  
Index Patient ◽  
Management Algorithm ◽  
Global Pandemic ◽  
Surgical Expertise ◽  
Systemic Symptoms ◽  
Specific Symptoms

Adrenal cysts are rare lesions that could be epithelial, endothelial, parasitic or haemorrhagic[1], as well as pseudocysts. Haemorrhagic adrenal cysts are extremely rare and are often asymptomatic, so diagnosis can be really challenging. This can prove really difficult for primary care physicians who are often the frontline clinicians these patients tend to present to. They are usually benign lesions and do not often cause mortality if detected early and prompt surgery is done, as was the case with the patient in our case report[4]. When they do become symptomatic, they can present with different systemic symptoms as documented in literature, including in our case report[2,4]. Diagnosis is usually through Ultrasound and CT Scan and management is largely laparoscopic or open excision depending on the size of the lesion, surgical expertise and local protocol. Most patients make full recovery and mortality is extremely low [3]. The aim of this review is to provide a broader overview of the subject, highlight salient points in several studies relating to haemorrhagic cysts, provide an up to date follow up information on the index patient in our case report and to explore possible areas for future study [4,6]. This review also includes a suggested management algorithm and intends to emphasize the fact that patients who present in primary, urgent or emergency care settings with persistent non-specific symptoms should be investigated for rare diseases.

Exogenous Cushing’s syndrome due to topical corticosteroid application: case report and review literature

Endocrine ◽  
2010 ◽  
Vol 38 (3) ◽  
pp. 328-334 ◽  
Author(s):  
Therdpong Tempark ◽  
Voraluk Phatarakijnirund ◽  
Susheera Chatproedprai ◽  
Suttipong Watcharasindhu ◽  
Vichit Supornsilchai ◽  
...  
Keyword(s):  
Case Report ◽  
Topical Corticosteroid ◽  
Cushing’S Syndrome ◽  
Cushing's Syndrome ◽  
Review Literature

Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Probably Related to Cefpodoxime: A Case Report

2019 ◽  
pp. 089719001986609 ◽  
Author(s):  
Tirin Babu ◽  
George Mathew Panachiyil ◽  
Juny Sebastian ◽  
Veeranna Shastry
Keyword(s):  
Case Report ◽  
Signs And Symptoms ◽  
Side Effect Profile ◽  
Drug Reactions ◽  
Dress Syndrome ◽  
First Case ◽  
Drug History ◽  
Drug Rash ◽  
Systemic Symptoms ◽  
Favorable Side Effect Profile

Cefpodoxime is a common antibiotic with a favorable side effect profile. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome has been described with several cephalosporins but not cefpodoxime. We report the probable first case of cefpodoxime-induced DRESS syndrome in a 52-year-old female patient. In our case, the patient presented with symptoms of DRESS syndrome 16 days after initiation of cefpodoxime. This case highlights the necessity of consideration of an iatrogenic reason for presenting signs and symptoms at all times. Reinforcing the importance of taking a thorough drug history and considering drug reactions even if onset of symptoms are delayed.

Sign in / Sign up

Export Citation Format

Share Document